Life science in the Cambridge Norwich Tech Corridor
The Cambridge Norwich Tech Corridor is at the forefront of a new era for life sciences and medtech as healthcare changes to meet the needs of our growing population.
Biotech is an area of specialism for the two major economies of the corridor. In Cambridge, the fast-growing Biomedical Campus at Addenbrooke’s Hospital, soon to be home to pharmaceutical giant AstraZeneca and global science supplier Abcam, complements the established hives of activity at Babraham Research Campus, Granta Park and the Wellcome Genome Campus. Life sciences is responsible for more than half of scientific R&D carried out in the city.
Many of the 3,000 researchers working at Norwich Research Park are dedicated to developing new techniques and therapies. Facilities include the Earlham Institute, home to the Earlham DNA Foundry, a specialist lab driving progress in the emerging field of synthetic biology.
The advent of personalised medicine, where treatments are tailored to individual patients, means a new wave of medical devices for
diagnosis and monitoring are about to hit clinics. The Tech Corridor is home to pioneers suchas Owlstone Medical, developer of a breath biopsy device that can ‘sniff out’ cancer using biomarkers on a patient’s breath. It is hoped the device, which won the 2018 MacRobert Award, UK engineering’s top prize, could save hundreds of thousands of lives by enabling the early detection of the disease.
For more details of the life science opportunities in the Tech Corridor, get in touch with our team.